[ET Net News Agency, 11 June 2020] Sino Biopharmaceutical Limited (01177) proposed a
bonus issue of shares on the basis of one new share for every two existing shares held by
the shareholders.
It is expected that a total of 6,291 million new shares would be allotted and issued
under the bonus issue plan, representing 50% of the existing issued share capital of the
company, or 33.33% of the enlarged issued share capital.
Meanwhile, the company has proposed to increase the authorised share capital of the
company to HK$750 million from HK$500 million by the creation of an additional 10,000
million new shares, to provide the company with greater flexibility for future
development. (KL)